Last reviewed · How we verify
NCT06332911: TEVAR
Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair
trial testing Shockwave™ Peripheral Intravascular Lithotripsy Balloon M5+ in Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture in 30 participants. Currently enrolling.
30 May 2026
Quick facts
| Lead sponsor | Rede Optimus Hospitalar SA |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 19 May 2025 |
| Primary completion | 30 May 2026 |
| Estimated completion | 30 May 2027 |
| Sites | 5 locations across Italy, Switzerland, Germany |
Drugs / interventions tested
- Shockwave™ Peripheral Intravascular Lithotripsy Balloon M5+
Conditions studied
- Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture — all drugs for Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture →
- Abdominal Aortic Aneurysm Without Rupture — all drugs for Abdominal Aortic Aneurysm Without Rupture →
- Thoracic Aortic Aneurysm Without Rupture — all drugs for Thoracic Aortic Aneurysm Without Rupture →
Sponsor
Rede Optimus Hospitalar SA
Who can join
18 and older, any sex, with Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture or Abdominal Aortic Aneurysm Without Rupture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Shockwave TEVAR is a nonrandomized, prospective, international, multi-center, PMCF, obervational study. The aim of this study is to evaluate the outcomes of the Shockwave™ Peripheral Intravascular Lithotripsy Balloon (Shockwave Medical Inc.) in the routine treatment of hostile iliac accesses during TEVAR and F/BEVAR.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06332911
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture
Currently open trials in the same condition.
- NCT03982940 — BGP+ Stent as Bridging Stent in BEVAR · NA · active not recruiting
Other Rede Optimus Hospitalar SA trials
Trials by the same sponsor.
- NCT06898086 — Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI) · NA · recruiting
- NCT05873842 — TRAns-Femoral Access Intravascular Lithotripsy Comparison With PTA in TAVI · recruiting
- NCT05625997 — Shockwave IVL + DCB · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06332911 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rede Optimus Hospitalar SA
- Last refreshed: 23 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06332911.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing